Engineering dextran-based scaffolds for drug delivery and tissue repair

Nanomedicine

Volumn 7, Issue 11, 2012, Pages 1771-1784

  Sun, Guoming ^a   Mao, Jeremy J ^a  

^a Department of Medicine   (United States)

Author keywords

dextran; hydrogel; stem cell; vascularization; wound healing

Indexed keywords

2 BROMOETHYLAMINE; ALGINIC ACID; AMIDE; AMINE; ANGIOPOIETIN 1; ARGINYLGLYCYLASPARTIC ACID; CHITOSAN; CHLOROACETIC ACID; CYTOKINE; DEXTRAN; FUNCTIONAL GROUP; GROWTH FACTOR; HYALURONIC ACID; HYDROXYL GROUP; MOLECULAR SCAFFOLD; MONOMER; NANOSPHERE; POLYMER; PROTEIN; SCATTER FACTOR; SOMATOMEDIN C; TISSUE SCAFFOLD; VASCULOTROPIN;

ANGIOGENESIS; BIODEGRADABILITY; BIODEGRADATION; CELL DIFFERENTIATION; CELL GROWTH; CHEMICAL MODIFICATION; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; ENDOTHELIAL PROGENITOR CELL; EXTRACELLULAR MATRIX; HUMAN; HYDROGEL; MOLECULAR INTERACTION; NANOENCAPSULATION; NANOENGINEERING; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STATIC ELECTRICITY; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; WOUND DRESSING; WOUND HEALING;

ANIMALS; BIOCOMPATIBLE MATERIALS; DEXTRANS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84870589393     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.149     Document Type: Review

References (100)

1. Naessens M, Cerdobbel A, Soetaert W, Vandamme EJ. Leuconostoc dextransucrase and dextran: production, properties and applications. J. Chem. Technol. Biotechnol. 80(8), 845-860 (2005). The production, properties and applications of dextrans are discussed.
2. Bachelder EM, Beaudette TT, Broaders KE, Dashe J, Frechet JM. Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications. J. Am. Chem. Soc. 130(32), 10494-10495 (2008).
3. Sun G, Chu CC. Synthesis, characterization of biodegradable dextran-allyl isocyanate-ethylamine/polyethylene glycol-diacrylate hydrogels and their in vitro release of albumin. Carbohydr. Polym. 65(3), 273-287 (2006).
4. Mitra S, Gaur U, Ghosh PC, Maitra AN. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J. Control. Release 74(1-3), 317-323 (2001).
5. Ferreira LS, Gerecht S, Fuller J, Shieh HF, Vunjak-Novakovic G, Langer R. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 28(17), 2706-2717 (2007).
6. Askari M, Fisher C, Weniger FG, Bidic S, Lee WP. Anticoagulation therapy in microsurgery: a review. J. Hand Surg. 31(5), 836-846 (2006).
7. Booi DI. Perioperative fuid overload increases anastomosis thrombosis in the free TRAM fap used for breast reconstruction. Eur. J. Plast. Surg. 34(2), 81-86 (2011).
8. Gombocz K, Beledi A, Alotti N et al. Infuence of dextran-70 on systemic infammatory response and myocardial ischaemia-reperfusion following cardiac operations. Crit. Care 11(4), R87 (2007).
9. Steinbauer M, Harris AG, Messmer K. Effects of dextran on microvascular ischemia-reperfusion injury in striated muscle. Am. J. Physiol.-Heart Circ. Physiol. 272(4), H1710-H1716 (1997).
10. Sakamaki F, Hoffmann H, Müller C, Dienemann H, Messmer K, Schildberg FW. Reduced lipid peroxidation and ischemia-reperfusion injury after lung transplantation using low-potassium dextran solution for lung preservation. Am. J. Respir. Crit. Care Med. 156(4), 1073-1081 (1997).
11. Banz Y, Gajanayake T, Matozan K, Yang Z, Rieben R. Dextran sulfate modulates MAP kinase signaling and reduces endothelial injury in a rat aortic clamping model. J. Vasc. Surg. 50(1), 161-170 (2009).
12. Robless P, Okonko D, Mikhailidis DP, Stansby G. Dextran 40 reduces in vitro platelet aggregation in peripheral arterial disease. Platelets 15(4), 215-222 (2004).
13. Dubniks M, Persson J, Grande PO. Comparison of the plasma volume-expanding effects of 6% dextran 70, 5% albumin, and 6% HES 130/0.4 after hemorrhage in the guinea pig. J. Trauma Inj. Infect. Crit. Care 67(6), 1200-1204 (2009).
14. Tam SC, Blumenstein J, Tzefeiwong J. Soluble dextran-hemoglobin complex as a potential blood substitute. Proc. Natl Acad. Sci. USA 73(6), 2128-2131 (1976).
15. Estevanato LL, Lacava LM, Carvalho LC et al. Long-term biodistribution and biocompatibility investigation of dextran-coated magnetite nanoparticle using mice as the animal model. J. Biomed. Nanotechnol. 8(2), 301-308 (2012).
16. Wilson R, Spiller DG, Beckett A, Prior IA, See V. Highly stable dextran-coated quantum dots for biomolecular detection and cellular imaging. Chem. Mater. 22(23), 6361-6369 (2010).
17. Latorre-Esteves M, Cortes A, Torres-Lugo M, Rinaldi C. Synthesis and characterization of carboxymethyl dextran-coated Mn/Zn ferrite for biomedical applications. J. Magn. Magn. Mater. 321(19), 3061-3066 (2009).
18. Hifumi H, Yamaoka S, Tanimoto A et al. Dextran coated gadolinium phosphate nanoparticles for magnetic resonance tumor imaging. J. Mater. Chem. 19(35), 6393-6399 (2009).
19. Franssen O, Vandervennet L, Roders P, Hennink WE. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. J. Control. Release 60(2-3), 211-221 (1999).
20. Liebert T, Hornig S, Hesse S, Heinze T. Nanoparticles on the basis of highly functionalized dextrans. J. Am. Chem. Soc. 127(30), 10484-10485 (2005).
21. Long LX, Yuan XB, Chang J et al. Self-assembly of polylactic acid and cholesterol-modifed dextran into hollow nanocapsules. Carbohydr. Polym. 87(4), 2630-2637 (2012).
22. Sun G, Chu CC. Self-assembly of chemically engineered hydrophilic dextran into microscopic tubules. ACS Nano 3(5), 1176-1182 (2009). Dextran can be engineered to self-assemble into tubule structures.
23. Sun G, Shen YI, Ho CC, Kusuma S, Gerecht S. Functional groups affect physical and biological properties of dextran-based hydrogels. J. Biomed. Mater. Res. Part A 93A(3), 1080-1090 (2010).
24. Sun GM, Chen FA, Chu CC. Effects of precursor and cross-linking parameters on the properties of dextran-allyl isocyanate-ethylamine/ poly(ethylene glycol diacrylate) biodegradable hydrogels and their release of ovalbumin. J. Biomater. Sci. Polym. Ed. 20(14), 2003-2022 (2009).
25. Van Tomme SR, Hennink WE. Biodegradable dextran hydrogels for protein delivery applications. Expert Rev. Med. Devices 4(2), 147-164 (2007). Dextran hydrogels are ideal carriers for protein delivery.
26. Tab at a Y. Tissue regeneration based on growth factor release. Tissue Eng. 9(Suppl. 1), S5-S15 (2003).
27. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263(5153), 1600-1603 (1994).
28. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55(3), 329-347 (2003).
29. Song C, Labhasetwar V, Cui X, Underwood T, Levy RJ. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model. J. Control. Release 54(2), 201-211 (1998).
30. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specifc nanoparticles: theory to practice. Pharmacol. Rev. 53(2), 283-318 (2001).
31. Cheng J, Teply BA, Sherif I et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery Biomaterials 28(5), 869-876 (2007).
32. Guo R, Zhang L, Qian H, Li R, Jiang X, Liu B. Multifunctional nanocarriers for cell imaging, drug delivery, and near-IR photothermal therapy. Langmuir 26 (8), 5428-5434 (2010).
33. Gref R, Minamitake Y, Peracchia M, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263(5153), 1600-1603 (1994).
34. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56(11), 1649-1659 (2004).
35. Passarella RJ, Spratt DE, Van Der Ende AE et al. Targeted nanoparticles that deliver a sustained, specifc release of paclitaxel to irradiated tumors. Cancer Res. 70(11), 4550-4559 (2010).
36. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70(1-2), 1-20 (2001).
37. Whitesides GM, Grzybowski B. Self-assembly at all scales. Science 295(5564), 2418-2421 (2002).
38. Letchford K, Burt H. A review of the formation and classifcation of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur. J. Pharm. Biopharm. 65(3), 259-269 (2007).
39. Sun G, Chu CC. Biodegradable nanospheres self-assembled from complementary hydrophilic dextran macromers. Carbohydr. Polym. 86 (2), 910-916 (2011).
40. Geng Y, Dalhaimer P, Cai S et al. Shape effects of flaments versus spherical particles in fow and drug delivery. Nat. Nanotechnol. 2(4), 249-255 (2007).
41. Zhao P, Liu L, Feng X, Wang C, Shuai X, Chen Y. Molecular nanoworm with PCL core and PEO shell as a non-spherical carrier for drug delivery. Macromol. Rapid Commun. 33(16), 1351-1355 (2012).
42. Kim Y, Dalhaimer P, Christian DA, Discher DE. Polymeric worm micelles as nano-carriers for drug delivery. Nanotechnology 16 (7), S484-S491 (2005).
43. Selinger J V, Schnur JM. Theory of chiral lipid tubules. Phys. Rev. Lett. 71(24), 4091-4094 (1993).
44. Yang WY, Lee E, Lee M. Tubular organization with coiled ribbon from amphiphilic rigid-fexible macrocycle. J. Am. Chem. Soc. 128(11), 3484-3485 (2006).
45. Yan D, Zhou Y, Hou J. Supramolecular self-assembly of macroscopic tubes. Science 303(5654), 65-67 (2004).
46. Raez J, Manners I, Winnik MA. Nanotubes from the self-assembly of asymmetric crystalline-coil poly(ferrocenylsilane-siloxane) block copolymers. J. Am. Chem. Soc. 124(35), 10381-10395 (2002).
47. Santoso S, Hwang W, Hartman H, Zhang S. Self-assembly of surfactant-like peptides with variable glycine tails to form nanotubes and nanovesicles. Nano Lett. 2(7), 687-691 (2002).
48. Percec V, Dulcey AE, Balagurusamy VS et al. Self-assembly of amphiphilic dendritic dipeptides into helical pores. Nature 430(7001), 764-768 (2004).
49. Zhang S, Marini DM, Hwang W, Santoso S. Design of nanostructured biological materials through self-assembly of peptides and proteins. Curr. Opin Chem. Biol. 6(6), 865-871 (2002).
50. Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA. Hydrogels in regenerative medicine. Adv. Mater. 21(32-33), 3307-3329 (2009).
51. Van Tomme SR, Storm G, Hennink WE. In situ gelling hydrogels for pharmaceutical and biomedical applications. Int. J. Pharm. 355(1-2), 1-18 (2008).
52. Schillemans JP, Verheyen E, Barendregt A, Hennink WE, Van Nostrum CF. Anionic and cationic dextran hydrogels for post-loading and release of proteins. J. Control. Release 150(3), 266-271 (2011).
53. Van Tomme SR, Van Steenbergen MJ, De Smedt SC, Van Nostrum CF, Hennink WE. Self-gelling hydrogels based on oppositely charged dextran microspheres. Biomaterials 26(14), 2129-2135 (2005).
54. Sun G, Chu CC. Impregnation of tubular self-assemblies into dextran hydrogels. Langmuir 26(4), 2831-2838 (2009).
55. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat. Biotech. 19(11), 1029-1034 (2001).
56. Wei J, Chen F, Shin JW et al. Preparation and characterization of bioactive mesoporous wollastonite-polycaprolactone composite scaffold. Biomaterials 30(6), 1080-1088 (2009).
57. Numata K, Yamazaki S, Naga N. Biocompatible and biodegradable dual-drug release system based on silk hydrogel containing silk nanoparticles. Biomacromolecules 13(5), 1383-1389 (2012).
58. Cao Y, Hong A, Schulten H, Post MJ. Update on therapeutic neovascularization. Cardiovasc. Res. 65(3), 639-648 (2005).
59. Sun G, Shen YI, Kusuma S, Fox-Talbot K, Steenbergen CJ, Gerecht S. Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors. Biomaterials 32(1), 95-106 (2011).
60. Rafi S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9(6), 702-712 (2003).
61. Dvir T, Kedem A, Ruvinov E et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc. Natl Acad. Sci. USA 106 (35), 14990-14995 (2009).
62. Saik JE, Gould DJ, Keswani AH, Dickinson ME, West JL. Biomimetic hydrogels with immobilized ephrinA1 for therapeutic angiogenesis. Biomacromolecules 12(7), 2715-2722 (2011).
63. Hanjaya-Putra D, Bose V, Shen YI et al. Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood 118(3), 804-815 (2011).
64. Mikos AG, Sarakinos G, Lyman MD, Ingber DE, Vacanti J P, Langer R. Prevascularization of porous biodegradable polymers. Biotechnol. Bioeng. 42(6), 716-723 (1993).
65. Phelps EA, Garcia AJ. Update on therapeutic vascularization strategies. Regen. Med. 4(1), 65-80 (2008).
66. Levenberg S, Rouwkema J, MacDonald M et al. Engineering vascularized skeletal muscle tissue. Nat. Biotechnol. 23(7), 879-884 (2005).
67. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24(24), 4337-4351 (2003).
68. Phelps EA, Landázuri N, Thule PM, Taylor WR, García AJ. Bioartifcial matrices for therapeutic vascularization. Proc. Natl Acad. Sci. USA 107(8), 3323-3328 (2010).
69. Sun G, Kusuma S, Gerecht S. The integrated role of biomaterials and stem cells in vascular regeneration. In: Biomaterials as Stem Cell Niche. Roy K (Ed.). SpringerVerlag, Berlin/Heidelberg, Germany, 195-223 (2010).
70. Kloxin AM, Kasko AM, Salinas CN, Anseth KS. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 324(5923), 59-63 (2009).
71. Kedem A, Perets A, Gamlieli-Bonshtein I, Dvir-Ginzberg M, Mizrahi S, Cohen S. Vascular endothelial growth factor-releasing scaffolds enhance vascularization and engraftment of hepatocytes transplanted on liver lobes. Tissue Eng. 11(5-6), 715-722 (2005).
72. Yamamoto M, Ikada Y, Tabata Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J. Biomater. Sci. Polym. Ed. 12(1), 77-88 (2001).
73. Ishihara M, Obara K, Ishizuka T et al. Controlled release of fbroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J. Biomed. Mater. Res. A 64(3), 551-559 (2003).
74. Silva EA, Mooney DJ. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J. Thromb. Haemost. 5(3), 590-598 (2007).
75. Nicodemus GD, Bryant SJ. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng. Part B Rev. 14(2), 149-165 (2008).
76. Guiducci S, Distler O, Distler JH, Matucci-Cerinic M. Mechanisms of vascular damage in SSc-implications for vascular treatment strategies. Rheumatology 47(Suppl. 5), v18-v20 (2008).
77. Moon JJ, Saik JE, Poche RA et al. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 31(14), 3840-3847 (2010).
78. Khetan S, Katz JS, Burdick JA. Sequential crosslinking to control cellular spreading in 3-dimensional hydrogels. Soft Matter 5(8), 1601-1606 (2009).
79. Asahara T, Bauters C, Zheng LP et al. Synergistic effect of vascular endothelial growth factor and basic fbroblast growth factor on angiogenesis in vivo. Circulation 92(9), 365-371 (1995).
80. Schulz JT 3rd, Tompkins RG, Burke JF. Artifcial skin. Annu. Rev. Med. 51(1), 231-244 (2000).
81. Kirker KR, Luo Y, Nielson JH, Shelby J, Prestwich GD. Glycosaminoglycan hydrogel flms as bio-interactive dressings for wound healing. Biomaterials 23(17), 3661-3671 (2002).
82. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 453(7193), 314-321 (2008).
83. Heng MC. Wound healing in adult skin: aiming for perfect regeneration. Int. J. Dermatol. 50(9), 1058-1066 (2011).
84. Li J, Zhang Y P, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc. Res. Tech. 60(1), 107-114 (2003).
85. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276(5309), 75-81 (1997).
86. Tredget EE. The basis of fbrosis and following thermal injury wound healing disorders. J. Trauma Inj. Infect. Crit. Care 62(6 Suppl.), S69 (2007).
87. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J. Investig. Dermatol. Symp. Proc. 5(1), 40-46 (2000).
88. Sun G, Zhang X, Shen YI et al. Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc. Natl Acad. Sci. USA 108(52), 20976-20981 (2011). Dextran hydrogels can restore complete skin structures without scar formation.
89. Weng L, Romanov A, Rooney J, Chen W. Non-cytotoxic, in situ gelable hydrogels composed of N-carboxyethyl chitosan and oxidized dextran. Biomaterials 29(29), 3905-3913 (2008).
90. Draye JP, Delaey B, Van De Voorde A, Van Den Bulcke A, De Reu B, Schacht E. In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel flms. Biomaterials 19(18), 1677-1687 (1998).
91. Körbling M, Estrov Z. Adult stem cells for tissue repair-a new therapeutic concept? N. Engl. J. Med. 349(6), 570-582 (2003).
92. Beachyphilip A, Karhadkarsunil S, Bermandavid M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432(7015), 324-331 (2004).
93. Shimizu T, Yamato M, Kikuchi A, Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24(13), 2309-2316 (2003).
94. Baskovich B, Sampson EM, Schultz GS, Parnell LK. Wound dressing components degrade proteins detrimental to wound healing. Int. Wound J. 5(4), 543-551 (2008).
95. Sun G, Zhang XZ, Chu CC. Formulation and characterization of chitosan-based hydrogel flms having both temperature and pH sensitivity. J. Mater. Sci. Mater. Med. 18 (8), 1563-1577 (2007).
96. Loh XJ, Cheong WCD, Li J, Ito Y. Novel poly(N-isopropylacrylamide)- poly[(R)-3-hydroxybutyrate]-poly(N-isopropylacrylamide) triblock copolymer surface as a culture substrate for human mesenchymal stem cells. Soft Matter 5 (15), 2937-2946 (2009).
97. Loh XJ, Gong J, Sakuragi M et al. Surface coating with a thermoresponsive copolymer for the culture and non-enzymatic recovery of mouse embryonic stem cells. Macromol. Biosci. 9(11), 1069-1079 (2009).
98. Wadajkar A, Koppolu B, Rahimi M, Nguyen K. Cytotoxic evaluation of N-isopropylacrylamide monomers and temperature-sensitive poly(N- isopropylacrylamide) nanoparticles. J. Nanoparticle Res. 11(6), 1375-1382 (2009).
99. Vihola H, Laukkanen A, Valtola L, Tenhu H, Hirvonen J. Cytotoxicity of thermosensitive polymers poly(N-isopropylacrylamide), poly(N-vinylcaprolactam) and amphiphilically modifed poly(N-vinylcaprolactam). Biomaterials 26(16), 3055-3064 (2005).
100. Sun G, Kusuma S, Gerecht S. Development of a biodegradable, temperature-sensitive dextran-based polymer as a cell-detaching substrate. Macromol. Biosci. 12(1), 21-28 (2012).